Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sunshine Biopharma (SBFM) Liabilities from Discontinued Operations (2018)

Historic Liabilities from Discontinued Operations for Sunshine Biopharma (SBFM) over the last 2 years, with Q4 2018 value amounting to $103732.0.

  • Sunshine Biopharma's Liabilities from Discontinued Operations changed N/A to $103732.0 in Q4 2018 from the same period last year, while for Dec 2018 it was $103732.0, marking a year-over-year change of. This contributed to the annual value of $103732.0 for FY2018, which is N/A changed from last year.
  • According to the latest figures from Q4 2018, Sunshine Biopharma's Liabilities from Discontinued Operations is $103732.0.
  • Over the past 5 years, Sunshine Biopharma's Liabilities from Discontinued Operations peaked at $103732.0 during Q4 2018, and registered a low of $103732.0 during Q4 2018.